Interpretation of Urine Albumin:Creatinine Ratio of 148 mg/mmol
A urine albumin:creatinine ratio (UACR) of 148 mg/mmol indicates severely increased albuminuria (macroalbuminuria), which represents significant kidney damage and requires immediate medical intervention. 1
Classification and Significance
According to the Kidney Disease Improving Global Outcomes (KDIGO) guidelines, albuminuria is categorized as follows:
- A1 (Normal to mildly increased): <30 mg/g (<3 mg/mmol)
- A2 (Moderately increased): 30-299 mg/g (3-29 mg/mmol)
- A3 (Severely increased): ≥300 mg/g (≥30 mg/mmol) 1
At 148 mg/mmol, this patient's result falls well into the A3 category (severely increased albuminuria), as it is significantly above the 30 mg/mmol threshold.
Clinical Implications
This level of albuminuria indicates:
Established kidney damage: This represents significant glomerular injury with increased permeability to albumin 1, 2
High risk for CKD progression: The patient is at substantially increased risk for progressive decline in kidney function 1
Elevated cardiovascular risk: Severely increased albuminuria is an independent risk factor for cardiovascular events and mortality 2, 3
Need for confirmation: Due to high biological variability (>20%) in urinary albumin excretion, this finding should be confirmed with 1-2 additional tests over a 3-6 month period to establish persistence 1
Recommended Follow-up Actions
Repeat testing: Confirm the elevated UACR with 1-2 additional measurements within 3-6 months 1
Comprehensive kidney function assessment:
- Measure estimated glomerular filtration rate (eGFR)
- Complete urinalysis to check for hematuria or other abnormalities
- Assess for other markers of kidney damage 1
Medication management:
Nephrology referral:
Risk factor modification:
Important Considerations
Potential false positives: Exercise within 24 hours, infection, fever, heart failure, marked hyperglycemia, menstruation, and severe hypertension can transiently elevate UACR 1
Variability: There is high within-individual variability in UACR measurements (coefficient of variation up to 48.8%), which is why confirmation with multiple samples is important 4
Monitoring frequency: Once confirmed, UACR should be monitored every 3-6 months to assess disease progression and treatment response 2
Treatment goal: Aim for at least a 30% reduction in UACR with treatment, with an ideal target of achieving UACR <30 mg/g 1
This level of albuminuria requires prompt attention as it indicates significant kidney damage and increased risk for both kidney disease progression and cardiovascular events.